Phase I and pharmacological study of the broad-spectrum tyrosine kinase inhibitor JNJ-26483327 in patients with advanced solid tumours

I.R.H.M. Konings, M.J.A. de Jonge, H. Burger, A. van der Gaast, L.E.C. van Beijsterveldt, H. Winkler, J. Verweij, Z. Yuan, P. Hellemans, F.A.L.M. Eskens

Research output: Contribution to journalArticleAcademicpeer-review

15 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)987-992
JournalBritish journal of cancer
Issue number7
Publication statusPublished - 2010

Cite this